CORRECTING and REPLACING Frost & Sullivan Recognizes ESTECH for Product Quality Leadership over Competitors.Business Editors/Health/Medical Writers CORRECTION...by Frost & Sullivan PALO ALTO, Calif.--(BUSINESS WIRE)--March 26, 2004 In BW5394 issued March 26, 2004: Third graph, first sentence should read: "ESTECH has constantly raised the bar in cardiovascular devices manufacturing, and its superior quality is validated by the number of successful surgeries and repeat usage by cardiac surgeons. (sted: "ESTECH has constantly raised the bar in cardiovascular devices manufacturing, and its superior quality is validated by the number of successful surgeries and repeat usage from cardiologists.) The corrected release reads: FROST & SULLIVAN RECOGNIZES ESTECH FOR PRODUCT QUALITY LEADERSHIP OVER COMPETITORS Frost & Sullivan's recent analysis, entitled U.S. Cardiac Surgery Markets, highlights the achievements of Endoscopic en·do·scope n. An instrument for examining visually the interior of a bodily canal or a hollow organ such as the colon, bladder, or stomach. en Technologies Inc. (ESTECH) in developing products and technologies that improve minimally invasive cardiovascular surgery cardiovascular surgery Heart surgery An operation for repairing structural defects of the cardiovascular system Examples CABG, repair of congenital heart defects, varicose veins, aortic aneurysms, ventricular remodeling, transmyocardial procedures while generating significant per-procedure hospital savings. For achieving significant growth with a prime focus on quality, enhancing customer satisfaction on a regular basis, and increasing repeat buying behavior, Frost & Sullivan has named ESTECH the recipient of the 2003 Frost & Sullivan Award for Product Quality Leadership. This award is presented each year to the company that has demonstrated superior product manufacturing quality control versus their existing competitors. "ESTECH has constantly raised the bar in cardiovascular devices manufacturing, and its superior quality is validated by the number of successful surgeries and repeat usage by cardiac surgeons. These are solid indications of the huge market potential for ESTECH's products," says Amit Bohora, senior research analyst with Frost & Sullivan. Since its inception in 1996, ESTECH has primarily focused on developing tools that facilitate less invasive surgical approaches for treatment of coronary artery disease coronary artery disease, condition that results when the coronary arteries are narrowed or occluded, most commonly by atherosclerotic deposits of fibrous and fatty tissue. , valvular valvular /val·vu·lar/ (val´vu-ler) pertaining to, affecting, or of the nature of a valve. val·vu·lar adj. Relating to, having, or operating by means of valves or valvelike parts. disease, and congenital heart defects Congenital heart defects Congenital means conditions which are present at birth. Congenital heart disease includes a variety of defects that babies are born with. Mentioned in: Heart Failure, Heart Surgery for Congenital Defects . ESTECH's portfolio combines internally developed products with licensed patents that enable totally endoscopic and ultra small incision coronary artery bypass surgery Coronary artery bypass surgery, also coronary artery bypass graft surgery, and colloquially heart bypass or bypass surgery is a surgical procedure performed to relieve angina and reduce the risk of death from coronary artery disease. (CABG CABG coronary artery bypass graft. CABG abbr. coronary artery bypass graft CABG Coronary artery bypass graft, see there ) on a beating heart. Using the ESTECH Access and Stabilization Systems together with a surgical robot, surgeons in the United States, Europe, and Asia Pacific have performed more than 100 "EndoCAB"(tm) minimally invasive (through a 2" incision) beating heart CABG procedures. The patented ESTECH retractor retractor /re·trac·tor/ (-trak´ter) 1. an instrument for holding open the lips of a wound. 2. a muscle that retracts. re·trac·tor n. 1. provides access to the chest cavity and heart through small incisions. Its stabilizer stabilizer: see airplane. system enables surgeons to attach the bypass graft while the heart is beating by isolating and controlling the artery on the surface of the heart. This avoids using the heart-lung machine that can increase the risk of stroke and other complications. Boston Scientific recently announced that it has made a strategic investment in and secured an exclusive option to acquire ESTECH. The companies are collaborating in the development of novel tools that will facilitate an endoscopic ablation procedure to treat atrial fibrillation ("EndoAFIB") through the combination of ESTECH's minimally invasive cardiac surgery minimally invasive cardiac surgery Interventional cardiology Any of a number of techniques–MIDCAB, off-pump coronary-artery bypass, minimally invasive valve surgery, port-access coronary surgery, and port-access valve surgery–increasingly being used to capabilities and Boston Scientific's ablation technology. EndoAFIB will enable many patients to have their arrhythmia arrhythmia (ārĭth`mēə), disturbance in the rate or rhythm of the heartbeat. Various arrhythmias can be symptoms of serious heart disorders; however, they are usually of no medical significance except in the presence of treated without having to undergo an invasive surgical procedure. Realizing ESTECH's tremendous growth potential, Telegraph Hill Partners L.P. and Psilos Group Managers L.P. recently co-led a $5 million Series B equity transaction. Funds will be used to enhance product quality and develop new devices for treatment of atrial fibrillation. Leveraging its reputation as a leader in product quality, ESTECH has successfully established agreements with leading distributors in domestic and foreign markets, ensuring extensive reach of its products and market presence in key international markets. About ESTECH Founded in 1996, ESTECH is a privately held company privately held company A firm whose shares are held within a relatively small circle of owners and are not traded publicly. with headquarters in Danville, Calif. The company is a recognized leader in Least Invasive Cardiac Surgery (LICS LICS Logic In Computer Science LICS Lotus International Character Set LICS Left Intercostal Space (cardiac anatomy) LICS Senior Chief Lithographer (Naval Rating) ), offering a complete system of products for both beating heart and stopped heart surgical approaches. ESTECH products have been used in thousands of procedures worldwide. For further information, visit http://www.estechlics.com. About Frost & Sullivan Founded in 1961, Frost & Sullivan is recognized as a global leader in growth consulting. Frost & Sullivan Awards are presented to companies that demonstrate excellence in their industry, commending the diligence, commitment, and innovative business strategies required to advance in the global marketplace. Frost & Sullivan rigorously analyzes specific criteria to determine award recipients in a vast variety of market industries and landscapes. For further information, visit www.frost.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion